Third Harmonic Bio, Inc.(NASDAQ:THRD) 
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by ...
Website: https://www.thirdharmonicbio.com
Founded: 2019
IPO Price: $17 (Sep 15, 2022)
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-02-18
P
O 3.64
H 3.64
L 3.46
C 3.49
V 750,360
10EMA 3.49
20EMA 3.49
60EMA 3.49
120EMA 3.49
250EMA 3.49